Here, we aimed to investigate how MIR31HG influenced lung cancer stem cell-mediated drug resistance, cellular invasion, and stemness features by epigenetically modulating GLI2 expression using mechanistic and functional analyses. This evidence concerns the gene GLI2 and lung carcinoma.